United States · FDA National Drug Code directory
CAPLYTA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72060-142_fa0963da-0db0-41f8-bb1a-153908a8bd77
- Product NDC
- 72060-142
- Form
- CAPSULE
- Composition / generic term
- lumateperone
- Labeler
- Intra-Cellular Therapies, Inc
- Marketing category
- NDA
- Marketing start / end (source format)
- 20200201
- Source listing expiry
- 20271231
Source-listed ingredients
- LUMATEPERONE — 42 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 7 CAPSULE in 1 BOTTLE (72060-142-07) · 72060-142-07
- 30 CAPSULE in 1 BOTTLE (72060-142-40) · 72060-142-40
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →